View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 17, 2022

Smithfield BioScience and BioCircuit to produce new Nerve Tape device

The nerve repair solution will allow surgeons to operate quickly and achieve re-joining of injured nerves.

Smithfield Foods ’ business unit Smithfield Bioscience and Biocircuit Technologies have announced plans to produce a new Nerve Tape medical device for nerve repair following traumatic injuries.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The implantable Nerve Tape device is made of decellularised porcine small intestinal submucosa (SIS) embedded with microscale hooks for tissue attachment.

The tape, which will enable nerve repair without sutures, will be prepared from SIS tissue harvested from the US operations of Smithfield.

It can easily be wrapped around two ends of a severed nerve to form a connection that will promote regeneration.

With the new technology, surgeons will be able to operate quickly and achieve re-joining of injured nerves.

This simplifies the surgical process and improves patient outcomes.

Biocircuit Technologies CEO Michelle Jarrard said: “BioCircuit is committed to developing medical technologies, such as Nerve Tape, to repair, monitor and control peripheral nerves precisely and reliably.

“We’re excited to tap into Smithfield’s exceptional level of traceability and product safety in our work to empower surgeons with powerful, practical clinical tools that improve the treatment of injuries.”

Simultaneously, the company is developing non-invasive, bioelectronic devices that can access nerve and muscle activity to provide sensitive monitoring and selective, closed-loop stimulation.

The bioelectronics technology can be used in neuromodulation, bioelectronic medicine, neuro-prosthetics and neuromuscular rehabilitation.

Using the technology, clinicians can diagnose health conditions earlier, provide treatment and track outcomes over time.

Smithfield Bioscience president Courtney Stanton said: “By harvesting porcine bioproducts for medical applications – such as organs, mucosa and tissues – we have the ability to improve lives through the development of innovative pharmaceuticals and medical devices like this one.”

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network